About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions 12-07-2024 at 6:31 PM EST Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting 12-03-2024 at 7:30 AM EST Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results 11-07-2024 at 4:05 PM EST VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Adaptive Biotechnologies Third Quarter Financial Results Nov 7, 2024 at 4:30 PM EST Listen to webcast Adaptive Biotechnologies Q3 2024 Earnings Presentation 1 MB Morgan Stanley 22nd Annual Global Healthcare Conference Sep 6, 2024 at 12:20 PM EDT Listen to webcast Adaptive Biotechnologies Second Quarter Financial Results Aug 1, 2024 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q2 2024 Earnings Presentation 816.1 KB VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Dec 22, 2024 6:19 AM ESTData Provided by Refinitiv. Minimum 15 minutes delayed.
